196 related articles for article (PubMed ID: 29167018)
21. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.
Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2014 Dec; 192(2):402-8. PubMed ID: 24998425
[TBL] [Abstract][Full Text] [Related]
23. Association between statin use and the prognosis of hepatocellular carcinoma after resection: a nationwide cohort study.
Jeon D; Cha HR; Chung SW; Choi J; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Lee SW; Choi WM
EClinicalMedicine; 2023 Nov; 65():102300. PubMed ID: 37965429
[TBL] [Abstract][Full Text] [Related]
24. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.
Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT
Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695
[TBL] [Abstract][Full Text] [Related]
25. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
26. Statin Use and Survival with Early-Stage Hepatocellular Carcinoma.
Jeon CY; Goodman MT; Cook-Wiens G; Sundaram V
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):686-92. PubMed ID: 26908429
[TBL] [Abstract][Full Text] [Related]
27. Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C.
Wei Q; Tian H; Luo HX; Zhang YC; Deng YN; Yao J; Li H; Chen GH; Yang Y
Asian J Surg; 2017 Nov; 40(6):453-462. PubMed ID: 27321176
[TBL] [Abstract][Full Text] [Related]
28. Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Lee HL; Lee SW; Jang JW; Bae SH; Choi JY; Yoon SK; Choi HJ; Na GH; You YK; Park IY; Kim DG
Liver Transpl; 2022 Mar; 28(3):397-406. PubMed ID: 34374192
[TBL] [Abstract][Full Text] [Related]
29. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort.
Sakamoto K; Beppu T; Hayashi H; Nakagawa S; Okabe H; Nitta H; Imai K; Hashimoto D; Chikamoto A; Isiko T; Kikuchi K; Baba H
Anticancer Res; 2015 Mar; 35(3):1647-55. PubMed ID: 25750323
[TBL] [Abstract][Full Text] [Related]
30. Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma.
Yamashita Y; Imai D; Bekki Y; Kimura K; Matsumoto Y; Nakagawara H; Ikegami T; Yoshizumi T; Shirabe K; Aishima S; Maehara Y
Ann Surg Oncol; 2015 Jul; 22(7):2279-85. PubMed ID: 25472646
[TBL] [Abstract][Full Text] [Related]
31. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
[TBL] [Abstract][Full Text] [Related]
33. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
34. Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling.
Kim DG; Yim SH; Min EK; Choi MC; Kim MS; Joo DJ; Lee JG
Liver Int; 2023 Sep; 43(9):2017-2025. PubMed ID: 37365992
[TBL] [Abstract][Full Text] [Related]
35. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
36. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
Lee JW; Hwang SH; Kim HJ; Kim D; Cho A; Yun M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1984-1994. PubMed ID: 28695236
[TBL] [Abstract][Full Text] [Related]
37. Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma.
Nishikawa H; Osaki Y; Arimoto A; Kita R; Kimura T
Anticancer Res; 2013 May; 33(5):2211-9. PubMed ID: 23645778
[TBL] [Abstract][Full Text] [Related]
38. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
39. Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection.
He C; Peng W; Li C; Wen TF
Medicine (Baltimore); 2017 Apr; 96(16):e6606. PubMed ID: 28422855
[TBL] [Abstract][Full Text] [Related]
40. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
